Observational Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Erenumab-aooe During Pregnancy (20180172) First published 14/10/2020 Last updated 22/11/2024 EU PAS number:EUPAS37499 Study Ongoing